Home
Conditions
Neuroblastoma

Clinical trial condition

Neuroblastoma

Explore clinical trials studying Neuroblastoma. Study availability and eligibility vary by location and protocol.

492 public trials 88 recruiting studies

Refine in advanced search Browse all conditions

Neuroblastoma trial results

Completed

Erlotinib and Temozolomide in Treating Young Patients With Recurrent or Refractory Solid Tumors

NCT00077454

Conditions: Astrocytoma, Familial ependymoma, Glioma, +28 more
Locations: COG Phase I Consortium Arcadia, California, United States

View Trial Details

Completed

Monoclonal Antibody Therapy in Treating Children With Metastatic Neuroblastoma in Second Remission

NCT00002458

Conditions: Neoplasms, Neoplasms by Histologic Type, Neoplasms, Germ Cell and Embryonal, +7 more
Locations: Memorial Sloan-Kettering Cancer Center New York, United States

View Trial Details

Completed

Oxaliplatin in Treating Young Patients With Recurrent Solid Tumors That Have Not Responded to Previous Treatment

NCT00091182

Conditions: Adenocarcinoma, Adrenal Cortex Diseases, Adrenal Cortex Neoplasms, +99 more
Locations: Children's Oncology Group Arcadia, California, United States

View Trial Details

Completed

Tanespimycin in Treating Young Patients With Recurrent or Refractory Leukemia or Solid Tumors

NCT00093821

Conditions: Childhood Chronic Myelogenous Leukemia, Childhood Desmoplastic Small Round Cell Tumor, Desmoplastic Small Round Cell Tumor, +36 more
Locations: Memorial Sloan-Kettering Cancer Center New York, United States

View Trial Details

Completed

Electroacupuncture in Treating Delayed Nausea and Vomiting in Patients Receiving Chemotherapy For Newly Diagnosed Childhood Sarcoma, Neuroblastoma, Nasopharyngeal Cancer, Germ Cell Tumors, or Hodgkin Lymphoma

NCT00040911

Conditions: Adnexal Diseases, Brain Diseases, Brain Neoplasms, +58 more
Locations: Warren Grant Magnuson Clinical Center - NCI Clinical Trials Referral Office Bethesda, Maryland, United States

View Trial Details

Completed

Combination Chemotherapy and Peripheral Stem Cell Transplantation in Treating Patients With Neuroblastoma

NCT00004188

Conditions: Neoplasms, Neoplasms by Histologic Type, Neoplasms, Germ Cell and Embryonal, +7 more
Locations: Comprehensive Cancer Center at University of Alabama at Birmingham Birmingham, Alabama, United States

Phoenix Children's Hospital Phoenix, Arizona, United States

Southern California Permanente Medical Group Downey, California, United States

Loma Linda University Cancer Institute at Loma Linda University Medical Center Loma Linda, California, United States

View all 96 locations

View Trial Details

Completed

Phase I/II Study of Escalating-Dose Melphalan w/Autologous SCS & Amifostine Cytoprotect

NCT00003425

Conditions: Adnexal Diseases, Blood Protein Disorders, Breast Cancer, +74 more
Locations: Albert B. Chandler Medical Center, University of Kentucky Lexington, Kentucky, United States

Marlene & Stewart Greenebaum Cancer Center, University of Maryland Baltimore, Maryland, United States

Kimmel Cancer Center of Thomas Jefferson University - Philadelphia Philadelphia, Pennsylvania, United States

Medical College of Wisconsin Milwaukee, Wisconsin, United States

View Trial Details

Completed

Ipilimumab After Allogeneic Stem Cell Transplant in Treating Patients With Persistent or Progressive Cancer

NCT00060372

Conditions: Adnexal Diseases, Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities, Adult Acute Myeloid Leukemia With Inv(16)(p13;q22), +148 more
Locations: Scripps Clinic - La Jolla La Jolla, California, United States

University of California San Diego La Jolla, California, United States

Blood and Marrow Transplant Group of Georgia Atlanta, Georgia, United States

Northside Hospital Atlanta, Georgia, United States

View Trial Details

Completed

Biological Therapy Following Chemotherapy and Peripheral Stem Cell Transplantation in Treating Patients With Cancer

NCT00003408

Conditions: Adnexal Diseases, Blast Crisis, Blood Protein Disorders, +122 more
Locations: Midwestern Regional Medical Center Zion, Illinois, United States

View Trial Details

Completed

Donor Natural Killer Cell Infusion in Preventing Relapse or Graft Failure in Patients Who Have Undergone Donor Bone Marrow Transplant

NCT00569283

Conditions: Adnexal Diseases, Blast Crisis, Blood Protein Disorders, +110 more
Locations: Korea Research Institute of Bioscience and Biotechnology Dajeon, South Korea

Asan Medical Center - University of Ulsan College of Medicine Seoul, South Korea

View Trial Details

Neuroblastoma

Neuroblastoma trial results

Related conditions